[Managing of excessive bleeding after cardiac surgery under cardiopulmonary bypass]

Area of Science:

• Cardiovascular Surgery
• Hemostasis Management
• Postoperative Complications

Context:

• Postoperative bleeding following cardiac surgery with cardiopulmonary bypass is a frequent complication.
• Reoperation is not always feasible, necessitating medical interventions.
• Current medical therapies are often empirical and used off-label.

Purpose:

• To review the current landscape of medical treatments for abnormal bleeding after cardiac surgery.
• To highlight the need for evidence-based guidelines.
• To emphasize the importance of determining the optimal risk/benefit ratio for each therapy.

Summary:

• Abnormal bleeding post-cardiac surgery is common, often requiring medical management when reoperation is not an option.
• Transfusion of blood products is standard, but other empirical, off-label therapies are frequently employed.
• Further clinical studies are essential to guide future treatment regimens and optimize patient outcomes.

Impact:

• Provides a foundation for developing evidence-based treatment protocols for postoperative bleeding in cardiac surgery.
• Aims to improve patient safety and reduce morbidity associated with bleeding complications.
• Guides future research to establish the efficacy and safety of various hemostatic agents.